157 related articles for article (PubMed ID: 20019119)
1. Introduction to Focus on Fabry nephropathy: biomarkers, progression, and disease severity.
Warnock DG; Remuzzi G; Brenner BM; Levin A; Wanner C
Clin J Am Soc Nephrol; 2010 Feb; 5(2):359. PubMed ID: 20019119
[No Abstract] [Full Text] [Related]
2. [Nephropathy in Fabry disease: possibilities for the radical improvement of prognosis for orphan diseases].
Fomin VV; Pulin AA; Mukhin NA
Ter Arkh; 2013; 85(6):4-9. PubMed ID: 23866592
[TBL] [Abstract][Full Text] [Related]
3. Biomarkers of Fabry disease nephropathy.
Schiffmann R; Waldek S; Benigni A; Auray-Blais C
Clin J Am Soc Nephrol; 2010 Feb; 5(2):360-4. PubMed ID: 19965549
[TBL] [Abstract][Full Text] [Related]
4. [Rare renal diseases: diagnosis and nephrological mangement of Anderson-Fabry disease].
Ranieri E
G Ital Nefrol; 2009; 26(1):10. PubMed ID: 19255957
[No Abstract] [Full Text] [Related]
5. Enzyme replacement therapy and Fabry nephropathy.
Warnock DG; Daina E; Remuzzi G; West M
Clin J Am Soc Nephrol; 2010 Feb; 5(2):371-8. PubMed ID: 20007680
[TBL] [Abstract][Full Text] [Related]
6. Department-related tasks and organ-targeted therapy in Fabry disease: an interdisciplinary challenge.
Weidemann F; Sommer C; Duning T; Lanzl I; Möhrenschlager M; Naleschinski D; Arning K; Baron R; Niemann M; Breunig F; Schaefer R; Strotmann J; Wanner C
Am J Med; 2010 Jul; 123(7):658.e1-658.e10. PubMed ID: 20609689
[TBL] [Abstract][Full Text] [Related]
7. Setting the agenda. Acute kidney injury.
Palevsky PM
Clin J Am Soc Nephrol; 2008 Jul; 3(4):933-4. PubMed ID: 18579670
[No Abstract] [Full Text] [Related]
8. Early detection and treatment of Fabry disease.
Breunig F
Clin Ther; 2008; 30 Suppl B():S45. PubMed ID: 18395137
[No Abstract] [Full Text] [Related]
9. [Fabry's disease: a form of chronic renal disease that may be diagnosed and treated].
Herrero Calvo JA
Nefrologia; 2008; 28(1):13-9. PubMed ID: 18336123
[No Abstract] [Full Text] [Related]
10. Kidney involvement in Anderson-Fabry disease.
Meroni M; Sessa A; Battini G; Tazzari S; Torri Tarelli L
Contrib Nephrol; 1997; 122():178-84. PubMed ID: 9399062
[No Abstract] [Full Text] [Related]
11. Dialysis and transplantation in Fabry disease: indications for enzyme replacement therapy.
Mignani R; Feriozzi S; Schaefer RM; Breunig F; Oliveira JP; Ruggenenti P; Sunder-Plassmann G
Clin J Am Soc Nephrol; 2010 Feb; 5(2):379-85. PubMed ID: 20056752
[TBL] [Abstract][Full Text] [Related]
12. Fabry disease: angiokeratoma, biomarker, and the effect of enzyme replacement therapy on kidney function.
Ries M; Schiffmann R
Arch Dermatol; 2005 Jul; 141(7):904-5; author reply 905-6. PubMed ID: 16027312
[No Abstract] [Full Text] [Related]
13. Cystatin C as a marker of early changes of renal function in Fabry nephropathy.
Feriozzi S; Germain DP; Di Vito R; Legrand A; Ricci R; Barbey F
J Nephrol; 2007; 20(4):437-43. PubMed ID: 17879210
[TBL] [Abstract][Full Text] [Related]
14. Natural history and treatment of renal involvement in Fabry disease.
Branton M; Schiffmann R; Kopp JB
J Am Soc Nephrol; 2002 Jun; 13 Suppl 2():S139-43. PubMed ID: 12068026
[No Abstract] [Full Text] [Related]
15. Bone and joint involvement in Fabry disease.
Sacre K; Lidove O; Giroux Leprieur B; Ouali N; Laganier J; Caillaud C; Papo T
Scand J Rheumatol; 2010 Mar; 39(2):171-4. PubMed ID: 20001766
[TBL] [Abstract][Full Text] [Related]
16. Recommendations and guidelines for the diagnosis and treatment of Fabry nephropathy in adults.
Ortiz A; Oliveira JP; Wanner C; Brenner BM; Waldek S; Warnock DG
Nat Clin Pract Nephrol; 2008 Jun; 4(6):327-36. PubMed ID: 18431378
[TBL] [Abstract][Full Text] [Related]
17. [Fabry disease and cystinosis, two lysosomal diseases: similarities and differences].
Grünfeld JP; Servais A
Rev Med Interne; 2010 Dec; 31 Suppl 2():S226-8. PubMed ID: 21211669
[TBL] [Abstract][Full Text] [Related]
18. Biomarkers of Fabry Nephropathy: Review and Future Perspective.
Levstek T; Vujkovac B; Trebusak Podkrajsek K
Genes (Basel); 2020 Sep; 11(9):. PubMed ID: 32962051
[TBL] [Abstract][Full Text] [Related]
19. [Clinical and histological findings in Fabry nephropathy].
Pieruzzi F; Salerno F; Di Giacomo A; Torti G; Ferrario F; Pagni F; Stella A
G Ital Nefrol; 2013; 30(6):. PubMed ID: 24402660
[TBL] [Abstract][Full Text] [Related]
20. Fabry nephropathy and the case for adjunctive renal therapy.
Wanner C; Breunig F
J Am Soc Nephrol; 2007 Sep; 18(9):2426-8. PubMed ID: 17699807
[No Abstract] [Full Text] [Related]
[Next] [New Search]
